FPH.AU Fisher & Paykel Healthcare Corporation Ltd

Healthcare Health Care Equipment & Supplies Australian Securities Exchange
38.13 AUD
Close of Nov 1, 2026
26.28 40.15
Market cap
AUD 22.4B
P/E
54.5x
P/B
13.29x
ROE
22.1%
Dividend yield
1.14%
Fundamental score
3.2/5

Ratios use the latest price and the fiscal year ending Mar 2026.

Is FPH.AU undervalued?

Graham number

The Graham number of Fisher & Paykel Healthcare Corporation Ltd cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Fisher & Paykel Healthcare Corporation Ltd fundamental analysis

14 of 22 checks passed

ROE 2/2

High return on equity (22.1%), above 20%.

ROA 1/1

Return on assets (16.4%) is above the industry median (-35.3%).

Profit Consistency 2/2

Profitable for 10 consecutive years.

Earnings Growth 5Y 0/1

Earnings per share did not grow over the past 5 years.

Earnings Acceleration 1/1

Last year's EPS growth (25.0%) is above the 5-year average (-2.5% a year).

Earnings Growth vs Industry 1/1

Last year's EPS growth (25.0%) is above the industry median (24.9%).

Revenue Growth 2/2

Revenue grew 14.0% a year over the past 3 years.

Short-term Liquidity 1/1

Current assets cover short-term liabilities.

Long-term Liabilities 1/1

Current assets cover long-term liabilities.

Debt to Equity 2/2

Low debt to equity (6.9%), 40% or less.

Debt Trend 1/1

Debt to equity has not risen over the past 5 years.

Debt Coverage 1/1

Operating cash flow covers 20% of total debt.

Interest Coverage 1/1

EBIT is 64.8x against interest expense, well covered.

PE vs Market 0/1

PE (54.5x) is above the market median (15.0x).

PE vs Industry 0/1

PE (54.5x) is above the industry median (36.4x).

PBV 0/1

Price to book (13.3x) is above the industry median (4.0x).

Graham Number 0/1

The price is above the Graham number (PE x PB = 724.0, limit 22.5).

PEG 0/1

PEG needs positive PE and positive 5-year earnings growth.

Dividend Yield 0/2

Dividend yield (1.0%) is in the bottom 25% of dividend payers in the market.

Dividend Stability 0/2

Dividends were not paid steadily for the past 5 years.

Dividend Growth 1/1

Dividends paid grew over the past 5 years.

Payout Ratio 1/1

Payout ratio is 53.9%, covered by earnings.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

Fisher & Paykel Healthcare Corporation Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Fisher & Paykel Healthcare Corporation Ltd

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. The company provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. It also offers adult respiratory products, including airvo system, optiflow na…

Full company profile